Ligand Pharmaceuticals | LGND - أصول متداولة





أصول متداولة تغيير تاريخ
Agenus USD 78.81M 16.47M 2026-06
Amgen USD 34.36B 598M 2026-09
Anika Therapeutics USD 99.19M 5.63M 2026-06
Arrowhead Research USD 1.29B 382.19M 2026-09
Baxter International USD 6.83B 163M 2026-09
Bristol-Myers Squibb USD 29.77B 1.19B 2026-09
Eli Lilly USD 65.26B 591M 2026-09
Enanta Pharmaceuticals USD 198.68M 5.65M 2025-12
Enviri Corporation USD 722.11M 1.43M 2026-03
Gilead Sciences USD 16.55B 4.02B 2026-09
GlaxoSmithKline GBP 17.9B 336M 2026-09
Glaxosmithkline GBP 17.9B 134M 2026-09
Heron Therapeutics USD 209.11M 20.73M 2026-09
Insmed USD 1.71B 72.59M 2026-09
Intrexon USD 23.72M 45.04M 2024-06
Ionis Pharmaceuticals USD 2.36B 129.77M 2026-09
Karyopharm Therapeutics USD 126.33M 23.19M 2026-03
Ligand Pharmaceuticals USD 608.23M 848.88M 2026-09
MacroGenics USD 295.08M 26.61M 2026-09
Merck USD 38.94B 2.26B 2026-09
Pacira USD 10.3B 9.68B 2026-09
Pfizer USD 45.01B 3.65B 2026-09
Rigel Pharmaceuticals USD 214.93M 39.53M 2025-09
Sangamo BioSciences USD 49.89M 12.3M 2025-06
Veracyte USD 467.88M 106.9M 2026-09